These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1726 related articles for article (PubMed ID: 8292895)

  • 1. Penetration and binding of L- and D-carboranylalanine in human melanoma spheroids.
    Pettersson OA; Olsson P; Lindström P; Sjöberg S; Carlsson J
    Melanoma Res; 1993 Oct; 3(5):369-76. PubMed ID: 8292895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
    Pettersson OA; Olsson P; Lindström P; Sjöberg S; Larsson BS; Carlsson J
    Acta Oncol; 1994; 33(6):685-91. PubMed ID: 7946449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of o-carboranylalanine as a potential boron delivery agent for neutron capture therapy.
    Yong JH; Barth RF; Wyzlic IM; Soloway AH; Rotaru JH
    Anticancer Res; 1995; 15(5B):2033-8. PubMed ID: 8572598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II.
    Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
    Clin Cancer Res; 1998 Aug; 4(8):1833-41. PubMed ID: 9717809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma.
    Fukuda H; Honda C; Wadabayashi N; Kobayashi T; Yoshino K; Hiratsuka J; Takahashi J; Akaizawa T; Abe Y; Ichihashi M; Mishima Y
    Melanoma Res; 1999 Feb; 9(1):75-83. PubMed ID: 10338337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
    Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
    Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
    Iwakura M; Kondoh H; Hiratsuka J; Ehara K; Tamaki N; Mishima Y
    Pigment Cell Res; 2002 Feb; 15(1):67-75. PubMed ID: 11837459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
    Gregoire V; Begg AC; Huiskamp R; Verrijk R; Bartelink H
    Radiother Oncol; 1993 Apr; 27(1):46-54. PubMed ID: 8327732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells.
    Papaspyrou M; Feinendegen LE; Müller-Gärtner HW
    Cancer Res; 1994 Dec; 54(24):6311-4. PubMed ID: 7987818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent.
    Matalka KZ; Barth RF; Staubus AE; Moeschberger ML; Coderre JA
    Radiat Res; 1994 Jan; 137(1):44-51. PubMed ID: 8265787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
    Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
    Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma.
    Tsuboi T; Kondoh H; Hiratsuka J; Mishima Y
    Pigment Cell Res; 1998 Oct; 11(5):275-82. PubMed ID: 9877098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
    Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
    Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
    Joel DD; Coderre JA; Micca PL; Nawrocky MM
    J Neurooncol; 1999 Feb; 41(3):213-21. PubMed ID: 10359141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
    Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
    Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of p-Boronophenylalanine.fructose in human patients with glioma and metastatic melanoma.
    Mallesch JL; Moore DE; Allen BJ; McCarthy WH; Jones R; Stening WA
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1183-8. PubMed ID: 8175404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Phenylalanine preloading reduces the (10)B(n, α)(7)Li dose to the normal brain by inhibiting the uptake of boronophenylalanine in boron neutron capture therapy for brain tumours.
    Watanabe T; Tanaka H; Fukutani S; Suzuki M; Hiraoka M; Ono K
    Cancer Lett; 2016 Jan; 370(1):27-32. PubMed ID: 26455769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
    Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
    J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.